Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)

Conditions: Hepatocellular Carcinoma Interventions: Drug: Bevacizumab combined with Sintilimab; Procedure: Transcatheter arterial chemoembolization Sponsors: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials